Compare COIN & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COIN | IQV |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0B | 35.1B |
| IPO Year | 2021 | 2013 |
| Metric | COIN | IQV |
|---|---|---|
| Price | $149.57 | $236.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 30 | 16 |
| Target Price | ★ $304.12 | $227.13 |
| AVG Volume (30 Days) | ★ 6.5M | 1.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | $7,181,325,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $3.76 | $6.77 |
| Revenue Next Year | $17.98 | $5.89 |
| P/E Ratio | ★ N/A | $141.74 |
| Revenue Growth | 9.40 | ★ 41.60 |
| 52 Week Low | $139.11 | $154.50 |
| 52 Week High | $402.16 | $251.36 |
| Indicator | COIN | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 66.05 |
| Support Level | $146.34 | $218.57 |
| Resistance Level | $177.02 | $247.52 |
| Average True Range (ATR) | 9.14 | 7.67 |
| MACD | -1.28 | 1.20 |
| Stochastic Oscillator | 29.66 | 73.22 |
Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange. While the company still generates the majority of its revenue from transaction fees charged to its retail customers, Coinbase uses internal investment and acquisitions to expand into adjacent businesses, such as prime brokerage and data analytics.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.